Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative bronchodilator therapy in lung cancer patients with severe COPD
ChiCTR1900022649Phase 4Not yet recruiting
- Sponsor
- Shanghai Pulmonary Hospital
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tiotropium, olodaterol and indacaterol in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by Shanghai Pulmonary Hospital. Primary endpoints: FEV1, FEV1% and 1 more. Planned start Apr 2019; status: not yet recruiting.
02
Drugs
tiotropiumolodaterolindacaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR1900022649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022649.